Biotechnology, Breakthrough Drugs, and Health Care Reform : Lessons from the NIH-University-Industry Relationship.

Examines the possible effects of price control strategies on the biotechnology community; its pursuit of research, development, and commercialization; and the ultimate availability of new, genetically-engineered therapeutics and diagnostics. Analyzes the interaction of the National Institutes of Hea...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 1994.
Series:	U.S. Congressional Research.
Subjects:	Pharmaceutical industry. Price regulation. Technology transfer. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Examines the possible effects of price control strategies on the biotechnology community; its pursuit of research, development, and commercialization; and the ultimate availability of new, genetically-engineered therapeutics and diagnostics. Analyzes the interaction of the National Institutes of Health (NIH) and the pharmaceutical industry.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.